Vor Ort
Merkzettel Warenkorb
Produktbild: Patient Compliance with Medications

Patient Compliance with Medications Issues and Opportunities

56,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

26.03.2007

Verlag

Taylor and Francis

Seitenzahl

252

Maße (L/B/H)

21/14,8/1,4 cm

Gewicht

470 g

Sprache

Englisch

ISBN

978-0-7890-2610-1

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

26.03.2007

Verlag

Taylor and Francis

Seitenzahl

252

Maße (L/B/H)

21/14,8/1,4 cm

Gewicht

470 g

Sprache

Englisch

ISBN

978-0-7890-2610-1

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
Die Leseprobe wird geladen.
  • Produktbild: Patient Compliance with Medications
  • About the Author -- Contributors -- Chapter 1. Introduction -- Chapter 2. Scope of Noncompliance and Other Issues -- Drugs, Pharmacists, and Insurance -- Self-care -- Self-medication -- Patient Compliance Issues -- Noncompliance As an Alternative -- The Consequences of Noncompliance -- Factors Affecting Compliance -- Dosing -- Devices to Aid Patient Compliance -- Communication -- Manufacturers -- Summary -- Chapter 3. Drug Therapies Leading to Noncompliant Activity - Jayashri Sankaranarayanan -- Introduction -- Medication Adherence or Compliance: Definitions, Estimates, Measurement, and Interventions -- Theoretical Aspects -- Structure and Demand of Drug Therapies -- Medical-condition-related Factors -- Medication-therapy-related Factors -- Patient-related Factors -- Health Professional Attributes and Health System Factors -- Conclusions and Future Directions -- Chapter 4. The Costs of Noncompliance -- Introduction -- Asthma -- Cardiovascular and Cerebrovascular Disease -- Diabetes -- Infectious Disease -- Seizures -- The Elderly -- Antipsychotic Therapy -- Transplantation Pharmacotherapy -- Chapter 5. Definitions and Measurement of Compliance -- Definitions of Compliance -- Noncompliance: Negative Connotations -- Measurement of Compliance -- Methods to Detect Compliance -- Physicians’ Estimates of Their Patients’ Compliance 85 Can Physicians Be Noncompliant? -- Chapter 6. Models to Evaluate Patient Compliance - Christopher Cook Health Belief Model -- Theory of Reasoned Action -- Theory of Planned Behavior -- Social Cognitive Theory -- Transtheoretical Model -- Other Models -- Conclusions -- Chapter 7. Methods to Impact Patient Compliance -- Types of Impacts on Compliance -- Specific Ways to Improve Compliance -- Getting into the Habit of Complying -- Other Considerations -- Summary -- Chapter 8. Bridging the Gap Between Provider and Patient Variables: Concordance -- The Concordance Movement in Concept and Action -- Concordance -- Chapter 9. Ethics of Compliance -- Capital Punishment and Assisted Suicide -- Noncompliance As a Patient Prerogative -- Health Insurance Portability and Accountability (HIPPA) Act and Impacts Upon Compliance -- Information Technology -- Questionable, If Not, Unethical Practices -- Pharmaceutical Company Research and Clinical Trials -- Chapter 10. The Role of Health Professionals in Influencing Patient Compliance - Richard Schulz -- Recognize Limitations and Biases -- Make Sense of the Vast and Contradictory Literature -- Commitment to the Development of Best Practices Regarding Medication Adherence -- Recent Trends in Compliance Research -- Summary -- Chapter 11. Disease State Management in Older Persons with Hyperlipidemia - Louis Roller, Jenny Gowan -- Lipid-lowering Agents -- Adherence to Lipid-lowering Therapy -- Scenario -- Identification of Drug Therapy Problems -- Possible Changes in Therapy and Benefits/Problems -- Possible Changes in Therapy -- Chapter 12. Current and Future Considerations -- Achieving Perfection? -- Complicated Considerations -- Physician and Drug Effects -- Questions (Important Factors) to Consider -- Future Considerations with Emerging Drug Therapies -- Where Do We Go from Here? -- Index.